Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RhBMP-2 vs. Autograft for Critical Size Tibial Defects: A Multicenter Randomized Trial

NCT00853489 is registered in ClinicalTrials.gov with St. Louis University as lead sponsor.

NCT NCT00853489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00853489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RhBMP-2 vs. Autograft for Critical Size Tibial Defects: A Multicenter Randomized Trial
Lead sponsor
St. Louis University
Phase
Phase 4
Overall status
Terminated
Start date
August 31, 2011
Completion date
February 17, 2017
Enrollment
33 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

tibial fractures